Back to Agenda
TOPIC 2 SESSION 6: Reporting Requirements in Special Situations in the Post-authorisation Phase and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Reporting Requirements in Special Situations in the Post-authorisation Phase and Case Studies
Sarah Vaughan
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Head of Vigilance Operations
Have an account?